US Broker Ratings

Solventum Corporation (SOLV) Stock Report: Is a 6.83% Upside Worth the Dive?

Solventum Corporation (SOLV), a prominent player in the healthcare sector, has been drawing attention with its diverse portfolio spanning Medsurg, Dental Solutions, and Health Information Systems. With a market capitalization..

Royalty Pharma plc (RPRX) Stock Analysis: Exploring Its 8.72% Upside and Strategic Biopharma Investments

Royalty Pharma plc (NASDAQ: RPRX) continues to capture investor interest as a unique entity in the healthcare sector, specifically within the biotechnology industry. Based in New York City and boasting..

Insmed Incorporated (INSM) Stock Analysis: Unveiling an 88.25% Potential Upside in Biotech Innovation

Investors keeping an eye on the healthcare sector, particularly biotechnology, may find Insmed Incorporated (NASDAQ: INSM) an intriguing opportunity. With a market capitalization of $23.03 billion, Insmed stands as a..

GSK plc (GSK) Stock Analysis: Attractive 12.23% Potential Upside Amid Strong Dividend Yield

Investors eyeing opportunities in the healthcare sector might find GSK plc (GSK) a compelling case, with its robust market presence and promising growth potential. Headquartered in London, GSK sits prominently..

Stryker Corporation (SYK) Stock Analysis: A Medical Device Leader with a 23% Upside Potential

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector known for its innovative medical devices, is capturing investor attention with a noteworthy potential upside of 23.02%. As the company..

Bristol-Myers Squibb (BMY) Stock Analysis: Evaluating Its 5.89% Upside Potential

For individual investors eyeing opportunities in the healthcare sector, Bristol-Myers Squibb Company (NYSE: BMY) presents a compelling case with its robust market presence and promising potential upside. With a market..

Incyte Corporation (INCY) Stock Analysis: Unlocking an 11% Upside with Robust Revenue Growth

Incyte Corporation (NASDAQ: INCY) stands tall in the biotechnology industry, a sector known for its innovation and rapid growth. With a market capitalization of $19.41 billion, Incyte is a notable..

Danaher Corporation (DHR) Investor Outlook: Evaluating a 44% Potential Upside

For investors eyeing opportunities in the healthcare sector, Danaher Corporation (NYSE: DHR) presents a noteworthy consideration. With a market capitalization of approximately $121.74 billion, Danaher is strategically positioned in the..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: A Precision Instrument Powerhouse with 20% Upside Potential

Mettler-Toledo International, Inc. (NYSE: MTD) is a prominent player in the diagnostics and research industry, offering a wide array of precision instruments and services. Headquartered in Greifensee, Switzerland, the company..

IDEXX Laboratories, Inc. (IDXX) Investor Outlook: Unveiling a 26.78% Potential Upside in the Diagnostics Arena

Investors with an eye on the healthcare sector should consider IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the diagnostics and research industry with a particular focus on animal..

AstraZeneca PLC (AZN) Stock Analysis: Strong Buy Ratings and a 20% Upside Potential

AstraZeneca PLC (NASDAQ: AZN), a prominent player in the healthcare sector, stands as a titan among global drug manufacturers. With a market capitalization of $290.06 billion, this UK-based biopharmaceutical company..

Medtronic plc (MDT) Stock Analysis: Exploring a 36% Potential Upside for Investors

Medtronic plc (NYSE: MDT), a titan in the medical devices industry, is capturing investor attention with a substantial potential upside of 36.23%. This renowned company, headquartered in Galway, Ireland, operates..

CVS Health Corporation (CVS) Stock Analysis: A Healthcare Giant with a 9.25% Potential Upside

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, offers a fascinating investment opportunity, especially for those interested in healthcare plans and services. With a market capitalization of..

Cardinal Health, Inc. (CAH) Stock Analysis: Unveiling a 22% Upside Potential in the Healthcare Sector

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, is capturing investor attention with a potential upside of 22.22%. With a robust market capitalization of $47 billion,..

Waters Corporation (WAT) Stock Analysis: Analyst Ratings Signal 16.99% Upside Potential

Waters Corporation (NYSE: WAT), a notable player in the healthcare sector, is making waves in the diagnostics and research industry. With a market capitalization of $33.62 billion, this U.S.-based company..

Humana Inc. (HUM) Stock Analysis: Navigating Healthcare Growth with Caution Amidst Valuation Concerns

Humana Inc. (NYSE: HUM), a leading player in the healthcare plans sector, represents a significant entity in the United States healthcare market. With a market capitalization of approximately $36.97 billion,..

STERIS plc (STE) Stock Analysis: Unveiling a Promising 18.60% Upside Potential

Investors with an eye on the healthcare sector have much to consider with STERIS plc (NYSE: STE), a prominent player in the medical devices industry. As a company specializing in..

DexCom, Inc. (DXCM) Stock Analysis: Strong Buy Ratings Signal Potential Upside

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector with a focus on medical devices, has been making significant strides in the continuous glucose monitoring (CGM) market. Headquartered in..

IQVIA Holdings, Inc. (IQV): Analyst Consensus Reveals 36% Upside Potential for Healthcare Giant

Investors with an eye on the healthcare sector should consider the promising outlook for IQVIA Holdings, Inc. (NYSE: IQV), a leader in the diagnostics and research industry. With a substantial..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A 30.72% Upside Potential Beckons Healthcare Investors

Intuitive Surgical, Inc. (NASDAQ: ISRG) has long been a trailblazer in the healthcare sector, especially within the niche of minimally invasive surgical systems. With its flagship da Vinci Surgical System,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds